The expanded gene mutation panel of the DNA‐RNA test contributed greatly to the diagnosis of thyroid cancer based on the specific molecular alteration detected (e.g. BRAF V600E), which is important for a ‘rule‐in’ test. This evidence concerns the gene BRAF and thyroid cancer.